Figure 1From: Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)Overall survival (A) and progression-free survival (B) of n = 10 consecutive patients with glioblastoma multiforme with oligodendroglial component (GBMO).Back to article page